Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism

Abroad (travel likely)Recruiting

Conditions

Autoimmune Encephalitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hospital Pitie Salpetriere, Paris, France
Contact: Study coordinator (Aurélie Kas, Pr) · aurelie.kas@aphp.fr · 01 42 17 62 81

Study leads

Aurélie Kas, Pr
Principal Investigator
Hôpital Pitié Salpêtrière - Assistance Publique Hôpitaux de Paris

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Cohort Study on Neuroimmune Diseases in the Reproductive Age

Neuromyelitis Optica Spectrum Disorders (NMOSD) · Multiple Sclerosis · Autoimmune Encephalitis

Abroad (travel likely)Recruiting

Guangzhou, China

A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease

Anti-N-methyl-D-aspartate Receptor (NMDAR) Encephalitis (ANRE) · Anti-N-methyl-D-aspartate Receptor (NMDAR) Antibody-associated Psychiatric Disease · Autoimmune Encephalitis

Abroad (travel likely)RecruitingPHASE2

Seoul, South Korea

CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases

Relapsing or Refractory Multiple Sclerosis (MS) · Myasthenia Gravis (MG) · Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Abroad (travel likely)RecruitingEARLY_PHASE1

Wuhan, China

Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.

Multiple Sclerosis (MS) · Neuromyelitis Optica Spectrum Disorder (NMOSD) · Autoimmune Encephalitis (AE)

Abroad (travel likely)RecruitingPHASE1

Wuhan, China